Evidence for a newly discovered cellular anti-HIV-1 phenotype
about
Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3GThe tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral vif proteinRing finger protein ZIN interacts with human immunodeficiency virus type 1 VifHIV-1 Nef promotes infection by excluding SERINC5 from virion incorporationRole and mechanism of action of the APOBEC3 family of antiretroviral resistance factorsHuman APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replicationHIV-1 Vif and APOBEC3G: multiple roads to one goalA second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteinsThe restriction factors of human immunodeficiency virusHIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factorsHIV-1 Vif, APOBEC, and intrinsic immunityInhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replicationComprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virionsIntracellular immunity to HIV-1: newly defined retroviral battles inside infected cells.HIV restriction in quiescent CD4⁺ T cellsSuppression of APOBEC3-mediated restriction of HIV-1 by VifFeline immunodeficiency virus Vif localizes to the nucleusIsolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif proteinLv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIVMAC/SIVSM/HIV-2 Lineage Prior to IntegrationVpu and BST2: Still Not There Yet?HIV and SIV infection: the role of cellular restriction and immune responses in viral replication and pathogenesisAPOBEC3G: an intracellular centurionThe enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity.Implication of the lymphocyte-specific nuclear body protein Sp140 in an innate response to human immunodeficiency virus type 1.Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells.The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity.Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction.APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication.Demonstration of a novel HIV-1 restriction phenotype from a human T cell lineHost genetic determinants of human immunodeficiency virus infection and disease progression in children.Multiple blocks to human immunodeficiency virus type 1 replication in rodent cellsAssociation of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcriptionLeveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.Cellular and viral specificities of human immunodeficiency virus type 1 vif protein.Human immunodeficiency virus and AIDS: insights from animal lentivirusesMinimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors.Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics.Species-specific, postentry barriers to primate immunodeficiency virus infection.Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA.
P2860
Q21146408-8FB13E71-F3D0-4DE3-8FB9-B17A3B988F5FQ24291013-28EE86A5-FD0D-4422-A494-4AB7BB1B1C78Q24304030-5902133A-3638-434D-9E70-E70CAAF65CAFQ24338895-987241F7-0EEE-4266-B7D1-A80843F87F96Q24537623-BA1F94B1-16DA-4FCD-9B49-C062F3075203Q24563503-FD72A88C-943A-4BF4-A160-C705ACBF2873Q24564072-95B01A62-936B-4F34-96B0-1F06E900FA2AQ24564187-01886297-EEA4-4AC2-97F8-D7DCF4A576D1Q24605108-752F1EED-C112-42B4-9E68-EE0975881A79Q24619114-BCA7A27C-D7BC-4B6A-9E64-9E191C2C6DE2Q24647833-002B798A-6913-49C7-B1AF-85CFF374D679Q24669993-4551A34C-AAEB-4170-9A03-F98224C0231CQ24678970-6D764238-90A2-440D-A0DE-B404D3FAFD86Q24805644-C0440059-A59B-43EB-81B1-8A62A2A09FD9Q26995784-92EBBD89-61E8-47BC-B862-451583B0F154Q27025150-41047202-53CA-4A33-BA74-4151DFBE56DAQ27469637-92AF210E-79C7-4747-A21F-A8281189962AQ27860488-02B5C415-51BE-4426-B84B-3F90327B05AEQ28546614-56C94315-A003-4911-A88D-F0A6E088F8A3Q28730708-7F9D5F75-1BED-45FF-80EA-6EA9D646664DQ28751706-68CA1EB1-9628-48C2-A138-3CA7D55BE3EAQ28754989-2AE0807E-73E4-45B3-9A71-03DD55487CCEQ30333471-0D01B895-4612-445D-BE36-8E9A2920495BQ30860339-7B51D624-DBA8-47C6-9D19-DE34AFFD938CQ30883515-E2652AB3-0D86-49C3-A911-1A42D1C64491Q31011512-04928AE0-2C27-48D9-87E3-FD37B1EEF26DQ33331396-ADE5AA0E-305F-4A8F-8B7D-A2EDD4C0C344Q33349452-3BA95625-B6A4-47C6-B587-755E9903A834Q33355942-2E009CB5-7AB0-4E6B-A446-B845E1E946FCQ33575664-10429572-3B08-4A5F-B006-F4FFC1A5C81FQ33603453-45764E94-7CCA-4585-A471-519AAEF59B0BQ33604247-A7B4C6BA-52D5-44A1-A5C4-21F9A3F9E165Q33654949-52490D74-4F6E-4785-9780-3CF23ACF5D84Q33806688-C797A2A3-6272-4B14-B9B1-9B7D232064CAQ33809273-988A6268-C17F-4A4E-AF77-A12B2958F887Q33814215-1D80CD85-FF8B-4377-BB10-C9DBB1DDE323Q33815187-C334CABE-165F-41EB-B4CB-91CC5DA5453EQ33824990-7F10F0C8-E849-480F-9CC7-55BD6DCFE0B5Q33841920-165F8E8F-508E-49B8-BF24-5DC1BFD5BD34Q33852465-D8B87803-997C-4B58-B2C1-E5247E4C911F
P2860
Evidence for a newly discovered cellular anti-HIV-1 phenotype
description
1998 nî lūn-bûn
@nan
1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Evidence for a newly discovered cellular anti-HIV-1 phenotype
@ast
Evidence for a newly discovered cellular anti-HIV-1 phenotype
@en
Evidence for a newly discovered cellular anti-HIV-1 phenotype
@nl
type
label
Evidence for a newly discovered cellular anti-HIV-1 phenotype
@ast
Evidence for a newly discovered cellular anti-HIV-1 phenotype
@en
Evidence for a newly discovered cellular anti-HIV-1 phenotype
@nl
prefLabel
Evidence for a newly discovered cellular anti-HIV-1 phenotype
@ast
Evidence for a newly discovered cellular anti-HIV-1 phenotype
@en
Evidence for a newly discovered cellular anti-HIV-1 phenotype
@nl
P2860
P356
P1433
P1476
Evidence for a newly discovered cellular anti-HIV-1 phenotype
@en
P2093
P2860
P2888
P304
P356
10.1038/3987
P407
P577
1998-12-01T00:00:00Z